news Researcher develops nanoelectronics for personalised immunotherapies 21 October 2022 | By Ria Kakkad (Drug Target Review) Dr Larysa Baraban, physicist at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) is researching a chip that should ultimately make it possible to develop personalised cancer immunotherapies.
article A novel blood-brain barrier model for cerebral malaria research 1 December 2020 | By Hannah Balfour (Drug Target Review) In this article Maria Bernabeu, Group Leader at EMBL, Barcelona, discusses why it is important to research and develop novel therapeutics for cerebral malaria and how her research group intends to develop a 3D blood-brain barrier model for this purpose.
news Genetic catalyst identifies the evolution of antibiotic resistance 26 April 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have shown that it is possible to identify genetic catalysts that accelerate the evolution of antibiotic resistance in bacteria...
news ERC invest nearly €2bn in European researchers 4 August 2017 | By Dr Zara Kassam (Drug Target Review) The European Research Council has announced its 2018 grant competitions with a total budget of around €1.86bn...
news New cellular imaging paves way for cancer treatment 13 June 2017 | By Niamh Marriott (Drug Target Review) Researchers have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease.
news Researchers discover neural stem cells that can become blood vessels 22 May 2017 | By Niamh Marriott (Drug Target Review) This finding could have a great impact on the study of paediatric tumours, as it could already constitute one of the factors that produces their growth.
news EU funds research on biofuels and infectious diseases 18 April 2017 | By Niamh Marriott (Drug Target Review) Biochemist and physician Professor Ivan Dikic and microbiologist Professor Volker Müller are very honoured that their pioneering research projects have been selected for this substantial financial support.
news Orion research foundation grants €1 million for research 14 February 2017 | By Niamh Marriott (Drug Target Review) Orion and Finland are both celebrating their centenaries in 2017.
news Pancreatic tumour tissue development stopped by vitamin A process 8 September 2016 | By Niamh Louise Marriott, Digital Content Producer Through a process involving vitamin A, researchers from Imperial College London observed that it was possible to switch off pancreatic stellate cells...